SEC Form 4 · accession 0001209191-17-012117
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul G Gabos
Director
Period of report
Feb 16, 2017
Accepted (ET)
Feb 17, 2017 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2017 | M | 10,668 | $32.325 | A | 21,923 | D | |
| Common Stock | Feb 16, 2017 | M | 10,668 | $27.715 | A | 32,591 | D | |
| Common StockF1 | Feb 16, 2017 | S | 21,336 | $69.6318 | D | 11,255 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $32.325 | Feb 16, 2017 | M | 10,668 | D | Nov 1, 2010 | Nov 1, 2017 | Common Stock | 10,668 | 0 | D |
| Stock Options (Right to Buy) | $27.715 | Feb 16, 2017 | M | 10,668 | D | May 23, 2011 | May 23, 2018 | Common Stock | 10,668 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is an weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $69.4250 to $69.78 for an average weighted sales price of $69.6318. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.